NM_001284292.2:c.939-1294G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001284292.2(NUTM1):c.939-1294G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.89 in 151,958 control chromosomes in the GnomAD database, including 60,551 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.89 ( 60551 hom., cov: 29)
Consequence
NUTM1
NM_001284292.2 intron
NM_001284292.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.420
Publications
6 publications found
Genes affected
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.935 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NUTM1 | NM_001284292.2 | c.939-1294G>A | intron_variant | Intron 4 of 7 | ENST00000537011.6 | NP_001271221.2 | ||
| NUTM1 | NM_001284293.2 | c.909-1294G>A | intron_variant | Intron 3 of 6 | NP_001271222.2 | |||
| NUTM1 | NM_175741.3 | c.855-1294G>A | intron_variant | Intron 4 of 7 | NP_786883.2 | |||
| NUTM1 | XM_047432341.1 | c.855-1294G>A | intron_variant | Intron 4 of 7 | XP_047288297.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NUTM1 | ENST00000537011.6 | c.939-1294G>A | intron_variant | Intron 4 of 7 | 2 | NM_001284292.2 | ENSP00000444896.1 | |||
| NUTM1 | ENST00000333756.5 | c.855-1294G>A | intron_variant | Intron 4 of 7 | 1 | ENSP00000329448.4 | ||||
| NUTM1 | ENST00000438749.7 | c.909-1294G>A | intron_variant | Intron 3 of 6 | 2 | ENSP00000407031.3 |
Frequencies
GnomAD3 genomes AF: 0.890 AC: 135186AN: 151840Hom.: 60513 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
135186
AN:
151840
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.890 AC: 135277AN: 151958Hom.: 60551 Cov.: 29 AF XY: 0.891 AC XY: 66157AN XY: 74286 show subpopulations
GnomAD4 genome
AF:
AC:
135277
AN:
151958
Hom.:
Cov.:
29
AF XY:
AC XY:
66157
AN XY:
74286
show subpopulations
African (AFR)
AF:
AC:
33460
AN:
41360
American (AMR)
AF:
AC:
13248
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
3211
AN:
3470
East Asian (EAS)
AF:
AC:
4086
AN:
5150
South Asian (SAS)
AF:
AC:
4231
AN:
4808
European-Finnish (FIN)
AF:
AC:
10056
AN:
10592
Middle Eastern (MID)
AF:
AC:
274
AN:
292
European-Non Finnish (NFE)
AF:
AC:
63993
AN:
67988
Other (OTH)
AF:
AC:
1905
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
729
1459
2188
2918
3647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2961
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.